Please use this identifier to cite or link to this item:
Title: Glufosfamide administered by 1-hour infusion as a second-line treatment for advanced non-small cell lung cancer; a phase II trial of the EORTC-New Drug Development Group
Institution and School/Department of submitter: Πανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικής
Keywords: Adolescent,Adult,Aged,Antineoplastic Agents/*administration & dosage/adverse effects/pharmacokinetics,Carcinoma, Non-Small-Cell Lung/*drug therapy,Child,Child, Preschool,Disease Progression,Drug Administration Schedule,Female,Glucose/analogs & derivatives,Humans,Ifosfamide/analogs & derivatives,Infusions, Intravenous,Lung Neoplasms/*drug therapy,Male,Middle Aged,Phosphoramide Mustards/*administration & dosage/adverse effects/pharmacokinetics,Prospective Studies
ISSN: 0959-8049
Appears in Collections:Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά)

Files in This Item:
File Description SizeFormat 
Giaccone-2004-Glufosfamide adminis.pdf169.83 kBAdobe PDFView/Open    Request a copy

This item is licensed under a Creative Commons License Creative Commons